Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
Hypoxia occurs in 90% of solid tumors and is associated with treatment failure, relapse, and mortality. HIF-1α signaling promotes resistance to chemotherapy in cancer cell lines and murine models via multiple mechanisms including the enrichment of breast cancer stem cells (BCSCs). In this work, we u...
Enregistré dans:
Auteurs principaux: | Inês Godet, Mahelet Mamo, Andrea Thurnheer, D. Marc Rosen, Daniele M. Gilkes |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/edee0cfbbc51437ca7bef0f721d1a1a4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Breast Cancer Recurrence Survival Among Iranian Patients; A 17-Year Retrospective Cohort Study
par: Amirreza Ehsani, et autres
Publié: (2021) -
Metastatic Breast Cancer to the Urinary Bladder in the Caribbean
par: Saara Mohammed, et autres
Publié: (2021) -
Opioids and Breast Cancer Recurrence: A Systematic Review
par: Merlino Lucia, et autres
Publié: (2021) -
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study
par: Lindsay J. Collin, et autres
Publié: (2021) -
MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
par: Cao,Danxia, et autres
Publié: (2020)